Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
The U.S. Supreme Court on Thursday unanimously backed the Securities and Exchange Commission’s ability to recover illegal profits through disgorgement, sustaining a lower-court ruling in a case brought by defendant Ongkaruck Sripetch. The decision leaves intact long-standing judicial and statutory foundations for disgorgement and resolves a central…
Hims & Hers Health shares rose 7.8% in morning trading as a Canaccord Genuity Buy rating with a $32 price target was reiterated and the company named Dr. Anant Vinjamoori as Chief Medical Officer for the Hims brand. Investors responded to the combination of renewed analyst conviction, a hire signaling deeper clinical capability, and the broader bac…
The U.S. Supreme Court on June 4 issued a unanimous decision siding with the Securities and Exchange Commission in a dispute over the scope of its disgorgement authority. The ruling affirms lower-court findings that the SEC may seek repayment of illegal profits even where the agency does not prove victims suffered monetary loss, and it follows liti…
Micron's AI-driven HBM adoption and strong cash generation justify an upgrade to a tactical long. Valuation is rich, but fundamentals and momentum support a mid-term trade into the June earnings window. Entry $1005.00, stop $930.00, target $1250.00, horizon: mid term (45 trading days).
The U.S. Supreme Court unanimously held that Hikma’s generic version of Amarin’s Vascepa did not infringe Amarin’s patents, rejecting a lower court ruling and potentially reducing the legal exposure of generic drugmakers that use so-called "skinny labels." The decision, supported by the Trump administration, centers on whether a generic manufacture…
Visa's headline legal risk has roiled sentiment, but the company’s capital-light network, $21.2B in free cash flow, and 51% return on equity argue for buying strength. This note lays out a tactical long trade with entry, stop, targets and the key risks that would invalidate the setup.
The International Atomic Energy Agency has told member states that Iran must promptly provide information on its enriched uranium following military strikes on its nuclear sites in June 2025. A confidential IAEA report says the agency has not received required information, has been denied access to most facilities except Bushehr, and cannot verify …
Paramount Skydance and the Ultimate Fighting Championship have struck a six-year pact that will make Paramount+ the exclusive home for UFC numbered-event main cards in Canada beginning next year. The arrangement expands on a previous U.S. rights deal and signals Paramount’s continued push to leverage live sports to drive growth in an increasingly m…
The recent sale of common stock by Marita Zuraitis, President and CEO of Horace Mann Educators Corp. (HMN), was reported alongside several key corporate developments for HMN. The transaction involved the disposal of a significant number of shares under a pre-arranged trading plan. Separately, the company released positive financial results for Q1 2…
Mexico's finance minister signaled that the country's economy could surpass the Organisation for Economic Co-operation and Development's (OECD) most recent growth forecast, citing an upcoming public investment programme focused on infrastructure and government steps to control inflation. The OECD projects 0.8% growth for 2026 and 1.8% for 2027, whi…
Five Below reported stronger-than-expected fiscal Q1 2026 results, yet its stock plunged 12.1% in morning trading after an after-hours selloff extended into the regular session. The company topped consensus on both earnings and revenue, driven by substantial comparable-store sales and higher transaction volume. The market reaction centered on the c…
Pinterest shares rose sharply after the company disclosed a $4 billion agreement naming Amazon Web Services its Preferred Cloud Services Provider through 2031. The pact is intended to accelerate Pinterest’s AI roadmap, improve search and shopping responsiveness, and update the platform’s infrastructure that supports visual discovery for over 600 mi…
RoboStrategy, Inc., a Nasdaq-listed closed-end fund providing exposure to private robotics and physical AI companies, will host a virtual investor presentation on June 10, 2026. The event will feature insights from the leadership and investment teams outlining the fund's unique opportunities, portfolio overview, and growth strategy.
Nexalin Technology announced the issuance of U.S. Patent No. 12,629,519 for its transcranial alternating current dynamic frequency stimulation method targeting anxiety, depression, and insomnia. This patent strengthens the company's intellectual property portfolio, supporting its proprietary DIFS™ technology and virtual NeuroCare™ model for non-inv…
Micron Technology shares dropped sharply in morning trading after a broad selloff in the semiconductor sector was sparked by Broadcom’s post-earnings reaction. Despite strong revenue results at Broadcom, management’s decision not to lift its full-year AI semiconductor revenue target prompted a steep decline in that stock and a sector-wide de-riskin…
Bank of America announced a cross-border real-time payments service scheduled for next quarter, allowing corporate, commercial and financial institution customers to send and receive instant funds via Swift or the bank's CashPro platform. The stock rose 2.4% on the news as the offering connects to several real-time rails and emphasizes full-princip…
Alphabet's $85 billion stock sale is larger than most corporate liquidity events and will materially increase tradable supply, alter ETF/prime broker flows and shift buyback math. That creates a short-term dislocation and a mid-to-long-term opportunity to buy quality cash flow at a modest multiple if management deploys proceeds rationally. Trade pl…
Rumble's shares jumped sharply after the company announced a $270 million, multi-year contract for dedicated GPU cloud capacity. The agreement, signed June 3, 2026, involves NVIDIA Blackwell B300 systems and may increase in value or duration tied to market performance. The deal strengthens Rumble's push into cloud services and AI compute as the fir…
FTAI Aviation ($251.58) is trading like an aviation services name but now carries optionality from FTAI Power's engine-to-turbine conversions and AI-driven operations with Palantir. The stock is richly valued, but upcoming data-center demand and recent strategic deals offer a clear mid-term trade setup.
MAIA Biotechnology reports strong patient enrollment and dosing progress in its pivotal Phase 3 THIO-104 clinical trial evaluating ateganosine, a first-in-class telomere-targeting therapy for third-line treatment of advanced non-small cell lung cancer (NSCLC). The therapy shows a high potential based on favorable Phase 2 results and holds significa…
Ciena shares dropped sharply after the company reported fiscal Q2 2026 results that exceeded Wall Street estimates on both earnings and revenue but failed to deliver the magnitude of upside investors had priced in. A modest raise to full-year revenue guidance, Q3 guidance that offered limited incremental surprise, persistent insider sell activity, …
Wolfe Research strategist Tobin Marcus says the effective U.S. tariff burden on imports has eased sharply this year, providing an under-the-radar boost to growth alongside AI-driven capital spending and consumer tax cuts. Marcus cautions, however, that a recent administration proposal to restore permanent tariffs under Section 301 - including a rat…
Publicis (PUBGY) looks like a classic opportunity to buy on fear: the business is cash-generative, pays a healthy yield, and is doubling down on AI through a strategic Microsoft relationship. Valuation is reasonable (P/E ~13.3, market cap ~$26.1B) and technical momentum is bullish. I upgrade to a buy and lay out an actionable trade with entry, stop…
U.S. Trade Representative Jamieson Greer said the United States will abide by the tariff ceilings set out in trade agreements with the European Union, Japan and other partners, while asserting that planned tariffs tied to forced-labour findings provide the legal mechanism to apply those duties. Greer spoke on the sidelines of an OECD ministerial in…
Akari Therapeutics, an oncology biotech company focused on antibody drug conjugates (ADCs) with novel RNA splicing modulator payloads, discussed its differentiated PH1 payload platform and promising preclinical data for KRAS-driven cancers at ASCO 2026. The company outlined its strategy to address resistance issues faced by traditional ADCs and ann…
